best day to take glp-1 shot Most Patients Keep Weight Off With Fewer Shots, Study Finds Taking GLP-1 a Day Early:

American Heart Journal, 267 , 111

The FDA labels for Zepbound and Wegovy both list acute cholecystitis and gallstones as possible risks

Excess weight is associated with venous stasis, particularly in the lower limbs, and obesity is a well-established risk factor for venous thromboembolism

We additionally accounted for sex, race, ethnicity, BMI prior to starting the GLP-1, change in BMI upon starting the GLP-1 as well as throughout their usage, use of osteoporosis medications, steroid use, smoking history, and comorbidities including hyperparathyroidism, chronic falls, cancer, CKD, malabsorption, IBD, and eating disorders in our analysis